Vertex Reports Fourth Quarter and Full Year Financial 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Vertex Pharma (VRTX) Tops Q4 EPS by 26c; Guides FY Revenue
February 7, 2023 4:02 PM ESTVertex Pharma (NASDAQ: VRTX) reported Q4 EPS of $3.79, $0.26 better than the analyst estimate of $3.53. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.3 billion.
GUIDANCE:
Vertex Pharma sees Q1 2023 revenue of $9.55-9.7 billion, versus the consensus... More
